Scott Langille

Scott Langille

No más puestos en curso
69 años
Health Technology
Consumer Services
Utilities

Perfil

Scott M.
Langille
worked as Director-Corporate Finance at Biovail Corp.
Served as CFO, Director & Head-Investor Relations at Aralez Pharmaceuticals Canada, Inc. from 2011 to 2016.
Held the position of Finance Director at AltiMed Pharmaceuticals Co. and Biovail Pharmaceuticals Canada.
Worked as Chief Financial Officer at Sparta Capital Ltd., Sernova Biotherapeutics, Inc. from 2016 to 2018, Wayland Group Corp., ViRexx Medical Corp.
from 2006 to 2007, Cipher Pharmaceuticals, Inc. from 2020 to 2022, and Pure Global Cannabis, Inc. in 2020.
Held the role of Vice President at Biovail Pharmaceuticals LLC and Controller at Zimmer of Canada Ltd. Education includes undergraduate studies at Toronto Metropolitan University and an MBA from the University of Toronto.

Antiguos cargos conocidos de Scott Langille.

EmpresasCargoFin
CIPHER PHARMACEUTICALS INC. Director Financiero/CFO 15/08/2022
PURE GLOBAL CANNABIS INC. Director Financiero/CFO 01/05/2020
SERNOVA BIOTHERAPEUTICS INC Director Financiero/CFO 04/05/2018
TRIBUTE PHARMACEUTICALS CANADA INC Director Financiero/CFO 01/01/2016
Director Financiero/CFO 01/05/2007
Ver el detalle de la experiencia de Scott Langille.

Formación de Scott Langille.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

16

Relaciones de 1er grado

14

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas14

Health Technology

Health Technology

Utilities

Health Technology

Process Industries

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

AltiMed Pharmaceuticals Co.

Zimmer of Canada Ltd.

Distribution Services

Health Technology

ÚLTIMAS HORA | -40%. Las herramientas más útiles solo para suscriptores: ¡descubre las mejores inversiones del futuro!
d
:
:
APROVECHAR LA PROMOCIÓN